Beta Bionics, Inc. (BBNX)
16.92
+1.22
(+7.80%)
USD |
NASDAQ |
Nov 09, 16:00
16.92
0.00 (0.00%)
After-Hours: 20:00
Beta Bionics Gross Profit Margin (Quarterly) : 57.26% for Sept. 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 57.26% |
| June 30, 2026 | 59.04% |
| March 31, 2026 | 59.50% |
| December 31, 2025 | 58.98% |
| September 30, 2025 | 55.48% |
| June 30, 2025 | 53.80% |
| March 31, 2025 | 50.86% |
| Date | Value |
|---|---|
| December 31, 2024 | 57.19% |
| September 30, 2024 | 53.36% |
| June 30, 2024 | 53.73% |
| March 31, 2024 | 55.68% |
| December 31, 2023 | 60.62% |
| September 30, 2023 | 39.61% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| PROCEPT BioRobotics Corp. | 66.28% |
| Edwards Lifesciences Corp. | 78.37% |
| Intuitive Surgical, Inc. | 68.35% |
| Stryker Corp. | 62.93% |
| Zimmer Biomet Holdings, Inc. | 62.67% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -27.50% |
| Return on Assets | -24.46% |
| Return on Invested Capital | -26.88% |
| Profit Margin (Quarterly) | -68.59% |
| Operating Margin (Quarterly) | -74.94% |
| Return on Net Operating Assets | -134.7% |